+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Anti-Venom Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • ID: 5578008
  • Report
  • April 2022
  • Region: Global
  • 145 Pages
  • IMARC Group

FEATURED COMPANIES

  • CSL Limited
  • Merck & Co. Inc.
  • Merck KGaA
  • MicroPharm Limited
  • Pfizer Inc.
The global anti-venom market reached a value of US$ 1,023.40 million in 2021. Looking forward, the market is projected to reach a value of US$ 1,544.40 million by 2027, exhibiting a CAGR of 6.80% during 2022-2027. Keeping in mind the uncertainties of COVID-19, the analyst is continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.



Anti-venoms are purified antibodies used to stop snake venom from binding to tissues and causing severe allergic reactions, blood-clotting, muscle injury, or nervous system problems. They can prevent or reverse the snakebite envenoming effects, which help minimize mortality and morbidity. They are obtained from different animal species, such as snakes, funnel web spiders, stonefish, redback spiders, and box jellyfish, using different technologies. Presently, the type of anti-venom generally used depends on the history and examination of the patient and geographic, clinical, and pathologic factors.

Anti-Venom Market Trends


The risk of snakebite envenoming is a public health hazard that people, especially in the rural areas, experience on a regular basis. It causes occupational injury among several agricultural workers and hunters, which represents one of the key factors driving the need for safe, effective, and affordable anti-venoms. In addition, open-plan housing and the practice of sleeping on the floor, common in tropical regions, can expose people to bites from nocturnal and highly venomous snakes and cause serious health problems. These health problems usually include kidney failure, severe paralysis that prevents breathing, bleeding disorders that can lead to fatal hemorrhage, and severe local tissue destruction that can cause permanent disability and result in limb amputation. This, in turn, is catalyzing the demand for anti-venoms across the globe. Apart from this, there is an introduction of snake venom detection kits with a rapid enzyme immunoassay for in vitro detection and immunological identification of snake venom in samples from bite sites, urine, plasma, blood, or other tissues and body fluids. This is anticipated to offer lucrative growth opportunities to industry players and drive the overall market.

Key Market Segmentation


This report provides an analysis of the key trends in each sub-segment of the global anti-venom market, along with forecasts at the global, regional and country level from 2022-2027. The report has categorized the market based on species, anti-venom type, mode of action and End-user.

Breakup by Species:

  • Snake
  • Scorpion
  • Spider
  • Others
  • Breakup by Anti-venom Type: Polyvalent Anti-venom
  • Monovalent Anti-venom

Breakup by Mode of Action:

  • Cytotoxic
  • Neurotoxic
  • Haemotoxic
  • Cardiotoxic
  • Myotoxic
  • Others

Breakup by End-user:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape


The competitive landscape of the industry has also been examined along with the profiles of the key players being Bharat Serums and Vaccines Limited (BSV), Boehringer Ingelheim International GmbH, Boston Scientific Corporation, CSL Limited, Haffkine Bio-Pharmaceutical Corporation Limited, Incepta Pharmaceuticals Limited, Merck & Co. Inc., Merck KGaA, MicroPharm Limited, Pfizer Inc. and Rare Disease Therapeutics Inc.

Key Questions Answered in This Report

  • How has the global anti-venom market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global anti-venom market?
  • What are the key regional markets?
  • What is the breakup of the market based on the species?
  • What is the breakup of the market based on the anti-venom type?
  • What is the breakup of the market based on the mode of action?
  • What is the breakup of the market based on the End-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global anti-venom market and who are the key players?
  • What is the degree of competition in the industry?
Frequently Asked Questions about the Global Anti-Venom Market

What is the estimated value of the Global Anti-Venom Market?

The Global Anti-Venom Market was estimated to be valued at $1023.4 Million in 2021.

What is the growth rate of the Global Anti-Venom Market?

The growth rate of the Global Anti-Venom Market is 7.1%, with an estimated value of $1544.4 Million by 2027.

What is the forecasted size of the Global Anti-Venom Market?

The Global Anti-Venom Market is estimated to be worth $1544.4 Million by 2027.

Who are the key companies in the Global Anti-Venom Market?

Key companies in the Global Anti-Venom Market include Bharat Serums and Vaccines Limited (BSV), Boehringer Ingelheim International GmbH, Boston Scientific Corporation, CSL Limited, Haffkine Bio, Pharmaceutical Corporation Limited, Incepta Pharmaceuticals Limited, Merck & Co. Inc. and MicroPharm Limited.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • CSL Limited
  • Merck & Co. Inc.
  • Merck KGaA
  • MicroPharm Limited
  • Pfizer Inc.

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Anti-venom Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Species
6.1 Snake
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Scorpion
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Spider
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Anti-venom Type
7.1 Polyvalent Anti-venom
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Monovalent Anti-venom
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Mode of Action
8.1 Cytotoxic
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Neurotoxic
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Haemotoxic
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Cardiotoxic
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Myotoxic
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Ambulatory Surgical Centers
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Bharat Serums and Vaccines Limited (BSV)
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Boehringer Ingelheim International GmbH
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Boston Scientific Corporation
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 CSL Limited
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Haffkine Bio-Pharmaceutical Corporation Limited
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Incepta Pharmaceuticals Limited
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Merck & Co. Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Merck KGaA
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 MicroPharm Limited
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Pfizer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Rare Disease Therapeutics Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
List of Figures
Figure 1: Global: Anti-venom Market: Major Drivers and Challenges
Figure 2: Global: Anti-venom Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Anti-venom Market: Breakup by Species (in %), 2021
Figure 5: Global: Anti-venom Market: Breakup by Anti-venom Type (in %), 2021
Figure 6: Global: Anti-venom Market: Breakup by Mode of Action (in %), 2021
Figure 7: Global: Anti-venom Market: Breakup by End User (in %), 2021
Figure 8: Global: Anti-venom Market: Breakup by Region (in %), 2021
Figure 9: Global: Anti-venom (Snake) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Anti-venom (Snake) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Anti-venom (Scorpion) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Anti-venom (Scorpion) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Anti-venom (Spider) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Anti-venom (Spider) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Anti-venom (Other Species) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Anti-venom (Other Species) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Anti-venom (Polyvalent Anti-venom) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Anti-venom (Polyvalent Anti-venom) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Anti-venom (Monovalent Anti-venom) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Anti-venom (Monovalent Anti-venom) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Anti-venom (Cytotoxic) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Anti-venom (Cytotoxic) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Anti-venom (Neurotoxic) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Anti-venom (Neurotoxic) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Anti-venom (Haemotoxic) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Anti-venom (Haemotoxic) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Anti-venom (Cardiotoxic) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Anti-venom (Cardiotoxic) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Anti-venom (Myotoxic) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Anti-venom (Myotoxic) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Anti-venom (Other Mode of Actions) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Anti-venom (Other Mode of Actions) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Anti-venom (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Anti-venom (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Anti-venom (Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Anti-venom (Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Anti-venom (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Anti-venom (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: North America: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: North America: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: United States: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: United States: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Canada: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Canada: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Asia-Pacific: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Asia-Pacific: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: China: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: China: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Japan: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Japan: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: India: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: India: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: South Korea: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: South Korea: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Australia: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Australia: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Indonesia: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Indonesia: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Others: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Others: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Europe: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Europe: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Germany: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Germany: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: France: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: France: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: United Kingdom: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: United Kingdom: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Italy: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Italy: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Spain: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Spain: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Russia: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Russia: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Others: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Others: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Latin America: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Latin America: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Brazil: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Brazil: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Mexico: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Mexico: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Others: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Others: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Middle East and Africa: Anti-venom Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Middle East and Africa: Anti-venom Market: Breakup by Country (in %), 2021
Figure 87: Middle East and Africa: Anti-venom Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: Global: Anti-venom Industry: SWOT Analysis
Figure 89: Global: Anti-venom Industry: Value Chain Analysis
Figure 90: Global: Anti-venom Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Anti-venom Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Anti-venom Market Forecast: Breakup by Species (in Million US$), 2022-2027
Table 3: Global: Anti-venom Market Forecast: Breakup by Anti-venom Type (in Million US$), 2022-2027
Table 4: Global: Anti-venom Market Forecast: Breakup by Mode of Action (in Million US$), 2022-2027
Table 5: Global: Anti-venom Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Anti-venom Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Anti-venom Market: Competitive Structure
Table 8: Global: Anti-venom Market: Key Players
Note: Product cover images may vary from those shown
  • Bharat Serums and Vaccines Limited (BSV)
  • Boehringer Ingelheim International GmbH
  • Boston Scientific Corporation
  • CSL Limited
  • Haffkine Bio-Pharmaceutical Corporation Limited
  • Incepta Pharmaceuticals Limited
  • Merck & Co. Inc.
  • Merck KGaA
  • MicroPharm Limited
  • Pfizer Inc.
  • Rare Disease Therapeutics Inc
Note: Product cover images may vary from those shown

Loading
LOADING...